Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...

Key findings from across the 21 scientific presentations on Alcon products will be presented at the meeting, including the soon-to-launch, first non-diffractive extended depth of focus AcrySof® IQ ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

Alcon (NYSE: ALC) today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India. Utilizing Alcon’s most advanced IOL material in its 20+ years of IOL innovation, Clareon ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Alcon ALC recently announced the U.S. introduction of its Clareon Toric intraocular lens (IOL) at the upcoming American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago. With this, the ...

BANGALORE, India, Sept. 1, 2026 /PRNewswire/ -- Alcon, a global leader in eye care, announced that TÜV SÜD has certified the Clareon ® Monofocal intraocular lens (IOL) for MDR compliance. This ...

Eye-care devices market is an attractive end-market supported by secular growth trends such as aging population, increased myopia prevalence, and innovation in products leading to better outcomes for ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of TOTAL30 ® Multifocal for Astigmatism, the ...